Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial
- Submitting institution
-
The University of Sheffield
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 6214
- Type
- D - Journal article
- DOI
-
10.1016/s0140-6736(20)30415-3
- Title of journal
- The Lancet
- Article number
- -
- First page
- 1268
- Volume
- 395
- Issue
- 10232
- ISSN
- 0140-6736
- Open access status
- Compliant
- Month of publication
- March
- Year of publication
- 2020
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
23
- Research group(s)
-
B - Cancer
- Citation count
- 50
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- (a) The author made a substantial contribution to the conception and design of the study; to carrying out the study; and to analysis and interpretation of study data. (b) The author helped draft the output.
- Non-English
- No
- English abstract
- -
